Amit Garg is currently Cofounder and Managing Partner at Tau Ventures, a seed fund in Palo Alto focused on applied AI in digital health, automation (cars, drones, robots), and enterprise. Their 15 current investments include ArmorCode (application security), Biotia (analyze pathogen genomes to prevent hospital contamination), Blendid (robotic arm for making food), Cerby (cybersecurity to harness shadow IT), Elemental Machines (IoT to improve production of foods+drugs), FidoCure (treat cancer in dogs), Freedom Robotics (cloud platform for robotics), Infinitus (helping patients navigate healthcare), Iterative Scopes (computer vision for colon cancer), RapidDeploy (unified public safety), RubiconMD (referral service for primary care physicians), Signos (weight loss through glucose monitoring), Totient (cancer drug discovery), and two investments in stealth.
Amit has been in Silicon Valley for 20 years — at Samsung NEXT Ventures where he seed-funded nuTonomy (self-driving cars, sold for $450M), cofounded a startup called HealthIQ (as of May 2019 a series D that has raised $120M and valued at $450M), at Norwest Ventures ($10B AUM), and doing product and analytics at Google. His academic training is BS in Computer Science and MS in Biomedical Informatics, both from Stanford, and MBA from Harvard. He speaks natively 3 languages, live carbon-neutral, a 70.3 Ironman finisher, and have built a hospital in rural India serving 100,000 people.